Helping to Bring Improved and Novel Therapies to the Right Patient Population Faster
Oncolines Hosts Webinar: Biomarkers for Patient Stratification & Target Engagement
Despite significant advances made in the treatment of cancer through the past decades, many new therapeutic entities fail in [...]
New Oncolines publication in Cancers
IL4I1 in ascites as a marker in high-grade serous ovarian cancer The emergence of immunotherapy has revolutionized [...]
Oncolines Team Joins Symeres
Symeres acquires Oncolines, further strengthening its drug discovery and biology capabilities Nijmegen, the Netherlands: Symeres, a [...]
Case study – Gene expression profiling to understand and combat drug resistancejanneke2023-05-29T15:56:23+02:00
Combination matrix to determine Bliss independence synergy scoresOncolines®2023-05-29T14:24:33+02:00
Case study – Pharmacological models to assess the role of tryptophan-metabolizing enzymes in cancerOncolines®2023-05-29T15:58:13+02:00
